ADO 4.35% 2.2¢ anteotech ltd

"Though improvements in the evaluation and labeling of troponin...

  1. 3,308 Posts.
    lightbulb Created with Sketch. 636
    "Though improvements in the evaluation and labeling of troponin tests are necessary, we support the current clinical practice guidelines and the way troponin tests are used. We look forward to working with all troponin test manufacturers to ensure that these tests, used as an aid to diagnose MI, are safe and effective for that purpose." Doesnt sound like they are that anti Troponin.. just making sure the device works as it should for its application.. currently nobody has.. who will be the first to bust down the door???? thats where you money should be

    LOL.. what are Abbots wasting their time and money on Troponin I for ? Well according to you its a waste of time.. its a wobbly path you run using trials of something you just said was no good as evidence of how long it can take for FDA approval???..

    BTW clinical trials is not FDA approval its a clinical trial and yes they run anywhere from 6-18months... ???? Once you have this infomration you make your application for FDA approval .. seriously whats your point.. Philips CLinical trials are already in place .. whats your point.. ???
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
-0.001(4.35%)
Mkt cap ! $54.21M
Open High Low Value Volume
2.3¢ 2.3¢ 2.2¢ $27.13K 1.224M

Buyers (Bids)

No. Vol. Price($)
13 1981203 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 757562 4
View Market Depth
Last trade - 16.10pm 20/05/2024 (20 minute delay) ?
Last
2.2¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
2.2¢ 2.3¢ 2.2¢ 271012
Last updated 15.31pm 20/05/2024 ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.